Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Drug response prediction in high-risk multiple myeloma
A. J. Vangsted
*
, S. Helm-Petersen, J. B. Cowland, P. B. Jensen, P. Gimsing, B. Barlogie, S. Knudsen
*
Corresponding author for this work
Department of Clinical Medicine
7
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drug response prediction in high-risk multiple myeloma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
High-risk Myeloma
100%
Prediction Score
80%
Clinical High Risk
40%
Bortezomib
40%
Progression-free Survival
40%
Gene Expression Profiling
40%
Tumor Samples
20%
Non-responders
20%
Myeloma
20%
Personalized Medicine
20%
Melphalan
20%
Drug Use
20%
Response to Treatment
20%
Working Diagnosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Progression Free Survival
100%
Bortezomib
100%
Multiple Myeloma
100%
Myeloma
100%
Melphalan
50%
Neoplasm
50%
Medicine and Dentistry
Drug Response
100%
Multiple Myeloma
100%
Gene Expression Profiling
40%
Progression Free Survival
40%
Bortezomib
40%
Myeloma
40%
Melphalan
20%
Neoplasm
20%
Cell Line
20%
Personalized Medicine
20%